Vancouver, Canada - Xenon Pharmaceuticals Inc., a drug discovery and development company, is pleased to announce today that it has appointed Vijay Sondhi as Chief Financial Officer.
“We are delighted to welcome Vijay to the Xenon team” commented Simon Pimstone, Xenon’s President and CEO. “Vijay brings a unique combination of entrepreneurial and executive experience that is relevant to Xenon as we build upon the recent Novartis transaction and advance further towards our goal of commercializing novel drugs. He has significant experience as the CFO of publicly traded and privately held fast growing technology companies. In addition, his venture capital industry and initial public offering experience will be valuable to Xenon as we move forward.”
Mr. Sondhi has spent the past 16 years in the high technology sector in Europe and the United States. He held CFO and co-CEO positions with IXOS Software AG (subsequently acquired by Open TextTM Corporation) where he led the company’s successful IPO on the NASDAQ and Frankfurt stock exchanges. He was also CFO of Fidelio Software GmbH where he assisted in the sale of the company to MICROS Systems, Inc. Mr. Sondhi’s most recent position was Managing Director at Allianz Venture Partners GmbH, a EURO 300 million venture capital fund based in Munich. Mr. Sondhi received an MBA from Columbia University, New York and a B.Sc. in Computer Science from the University of British Columbia, Vancouver.
About Xenon Pharmaceuticals Inc.
Xenon is a privately owned, clinical genetics-based drug discovery and development company engaged in developing small molecule therapies based on the genetic causes of select metabolic, neurological and cardiovascular diseases. For more information, visit the Company's website at www.xenon-pharma.com.
This release contains forward-looking statements that are not based on historical fact. These forward-looking statements involve risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on such forward-looking statements.
# # # 
